ELICA 0.1% CREAM 30G

Indications

Approved Uses

Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (e.g., atopic dermatitis/eczema and psoriasis).

Dosage & Administration

Dosing by Condition

Corticosteroid-responsive dermatoses (including atopic dermatitis and psoriasis): apply a thin layer to affected areas once daily; reassess if no improvement within ~2 weeks; avoid routine occlusion and reserve for specialist direction in resistant plaques.

Initial Dose

Apply a thin film to the affected skin areas once daily.

Maintenance Dose

Apply a thin film to the affected skin areas once daily as needed for control. Therapy should be discontinued when control is achieved.

Maximum Dose

Apply a thin layer once daily; use the lowest amount for the shortest duration-reassess if no improvement within ~2 weeks; avoid prolonged continuous use especially on face/intertriginous areas and avoid large-area/occlusive use.

Side Effects

Common Side Effects

Common local effects: burning/stinging/tingling, pruritus, irritation/dryness/erythema; less common but clinically important with prolonged use: skin atrophy, striae, telangiectasia, hypopigmentation, folliculitis/acneiform eruptions, and secondary infection/contact dermatitis.

Side Effect Frequency

Common: application-site burning/stinging, pruritus, irritation/dryness; Uncommon: folliculitis, acneiform eruption, hypopigmentation, hypertrichosis, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, telangiectasia, miliaria; Rare: HPA-axis suppression/Cushingoid effects, hyperglycemia (risk increases with high dose, large area, occlusion, prolonged use, pediatrics).

Safety & Warnings

Warnings & Precautions

Avoid eyes/mucosa and periocular use; avoid occlusion unless directed; do not use on untreated infections-treat infection appropriately and stop if not controlled; use caution/limit duration on face, groin, axillae and in children due to higher absorption; avoid use for diaper rash; discontinue if irritation/sensitization occurs and reassess if no response within ~2 weeks.

Driving Warning

Safe

Drug Interactions

Food Interaction

No clinically relevant food interactions (not applicable for topical administration).

Special Populations

Elderly

Standard adult dosing; use with caution as elderly skin is more susceptible to atrophy and striae

Storage & Patient Advice

Patient Counseling

Apply a thin layer to affected skin once daily as prescribed; avoid eyes/mucosa; do not use on face/groin/axillae or under occlusion unless directed; do not use on infected skin unless treated; use the smallest amount for the shortest duration and seek review if not improving within ~2 weeks; avoid use for diaper rash; do not share (prescription-only).

Monitoring Requirements

Monitor clinical response and local adverse effects (atrophy, striae, telangiectasia, dermatitis, infection); consider HPA-axis suppression monitoring if used long-term, on large surface areas, under occlusion, in children, or on thin-skin areas; reassess need regularly.

Pharmacology

Mechanism of Action

Synthetic glucocorticoid that binds intracellular glucocorticoid receptors to alter gene transcription, inducing lipocortins that inhibit phospholipase A2 and reducing prostaglandin/leukotriene and cytokine-mediated inflammation, producing anti-inflammatory, antipruritic, and vasoconstrictive effects.

Duration of Effect

Approximately 24 hours per application (supports once-daily dosing).

Bioavailability

Minimal systemic absorption from intact skin (about 0.4-0.7%); absorption increases with inflammation, large surface area, prolonged use, occlusion, or thin-skin areas.

Product Information

Available Dosage Forms

Cream (this product per verified API data); mometasone furoate is also commonly available in other markets as ointment and lotion/solution (including scalp solution), but availability is product/market specific.

Composition per Dose

Each gram of cream: 1 mg mometasone furoate (0.1%) in a cream base

Skin Condition

Eczema, Psoriasis, Dermatitis

Steroid Potency

Potent

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.